| Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration V Margulis, SF Shariat, SF Matin, AM Kamat, R Zigeuner, E Kikuchi, ... Cancer 115 (6), 1224-1233, 2009 | 1112 | 2009 |
| Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial MD Galsky, JÁA Arija, A Bamias, ID Davis, M De Santis, E Kikuchi, ... The Lancet 395 (10236), 1547-1557, 2020 | 647 | 2020 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 402 | 2021 |
| Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) F Soria, SF Shariat, SP Lerner, HM Fritsche, M Rink, W Kassouf, ... World journal of urology 35, 379-387, 2017 | 335 | 2017 |
| Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma E Kikuchi, V Margulis, PI Karakiewicz, M Roscigno, S Mikami, Y Lotan, ... Journal of clinical oncology 27 (4), 612, 2009 | 305 | 2009 |
| Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration NJ Hellenthal, SF Shariat, V Margulis, PI Karakiewicz, M Roscigno, ... The Journal of urology 182 (3), 900-906, 2009 | 238 | 2009 |
| Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma EK Cha, SF Shariat, M Kormaksson, G Novara, TF Chromecki, DS Scherr, ... European urology 61 (4), 818-825, 2012 | 217 | 2012 |
| Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases U Capitanio, SF Shariat, H Isbarn, A Weizer, M Remzi, M Roscigno, ... European urology 56 (1), 1-9, 2009 | 215 | 2009 |
| The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy TF Chromecki, EK Cha, H Fajkovic, V Margulis, G Novara, DS Scherr, ... European urology 61 (2), 245-253, 2012 | 208 | 2012 |
| Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract V Margulis, RF Youssef, PI Karakiewicz, Y Lotan, CG Wood, R Zigeuner, ... The Journal of urology 184 (2), 453-458, 2010 | 207 | 2010 |
| Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy M Roscigno, SF Shariat, V Margulis, P Karakiewicz, M Remzi, E Kikuchi, ... The Journal of urology 181 (6), 2482-2489, 2009 | 206 | 2009 |
| Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy JD Raman, CK Ng, DS Scherr, V Margulis, Y Lotan, K Bensalah, JJ Patard, ... European urology 57 (6), 1072-1079, 2010 | 199 | 2010 |
| Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract R Zigeuner, SF Shariat, V Margulis, PI Karakiewicz, M Roscigno, A Weizer, ... European urology 57 (4), 575-581, 2010 | 187 | 2010 |
| Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients M Remzi, A Haitel, V Margulis, P Karakiewizc, F Montorsi, E Kikuchi, ... BJU international 103 (3), 307-311, 2009 | 187 | 2009 |
| Is tumor volume an independent prognostic factor in clinically localized prostate cancer? E Kikuchi, PT Scardino, TM Wheeler, KM Slawin, M Ohori The Journal of urology 172 (2), 508-511, 2004 | 185 | 2004 |
| The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? M Roscigno, SF Shariat, V Margulis, P Karakiewicz, M Remzi, E Kikuchi, ... European urology 56 (3), 512-519, 2009 | 167 | 2009 |
| Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy SF Shariat, G Godoy, Y Lotan, M Droller, PI Karakiewicz, JD Raman, ... BJU international 105 (12), 1672-1677, 2010 | 156 | 2010 |
| Interleukin 6 is associated with cachexia in patients with prostate cancer K Kuroda, J Nakashima, K Kanao, E Kikuchi, A Miyajima, Y Horiguchi, ... Urology 69 (1), 113-117, 2007 | 154 | 2007 |
| Suppression of hormone-refractory prostate cancer by a novel nuclear factor κB inhibitor in nude mice E Kikuchi, Y Horiguchi, J Nakashima, K Kuroda, M Oya, T Ohigashi, ... Cancer Research 63 (1), 107-110, 2003 | 146 | 2003 |
| Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time G Ploussard, SF Shariat, A Dragomir, LA Kluth, E Xylinas, ... European urology 66 (2), 361-370, 2014 | 145 | 2014 |
